Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6001752 | 0.82 | DAO (0.32) | — | |
| SCHEMBL15110938 | 0.78 | CES2 (0.31) | — | |
| SCHEMBL7468245 | 0.78 | DAO (0.42) | — | |
| SCHEMBL16369693 | 0.78 | — | — | |
| SCHEMBL128751 | 0.78 | — | — | |
| SCHEMBL10567380 | 0.74 | PTPN2 (0.31) | — | |
| SCHEMBL10980278 | 0.74 | KIF11 (0.33) | — | |
| SCHEMBL27397192 | 0.72 | RXRA (0.44) | — | |
| SCHEMBL29049111 | 0.71 | LTB4R (0.43) | — | |
| SCHEMBL28159091 | 0.70 | PTPN5 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084072-A1 | GLP-1R MODULATING COMPOUNDS | GILEAD SCIENCES, INC. | 2025-03-13 | — | — | US | disclosed |
| US-12091404-B2 | GLP-1R modulating compounds | GILEAD SCIENCES, INC. (US) | 2024-09-17 | — | — | US | disclosed |
| EP-4304711-A1 | GLP-1R MODULATING COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2024-01-17 | — | — | EP | disclosed |
| US-20220298148-A1 | GLP-1R MODULATING COMPOUNDS | GILEAD SCIENCES, INC. | 2022-09-22 | — | — | US | disclosed |
| WO-2022192428-A1 | GLP-1R MODULATING COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2022-09-15 | — | — | WO | disclosed |
| US-4515618-A | PLANT GROWTH REGULATORS | CHEVRON RESEARCH COMPANY (US) | 1985-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220298148-A1 | GLP-1R MODULATING COMPOUNDS | GLP1R, GIPR, GPR119 | PTPN1 925/4885GSK3B 513/4885 |
| US-12091404-B2 | GLP-1R modulating compounds | GLP1R, GIPR, GPR119 | PTPN1 925/4885GSK3B 513/4885 |
| US-20250084072-A1 | GLP-1R MODULATING COMPOUNDS | GLP1R, GIPR, GPR119 | PTPN1 925/4885GSK3B 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.